Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX4211 adjunct therapy in adults with type 1 diabetes mellitus
2014-005153-39Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sotagliflozin in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Lexicon Pharmaceuticals, Inc. Started Mar 2015; status: completed.
02
Drugs
sotagliflozin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-005153-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005153-39.